Jivraj S, Rai R, Underwood J, Regan L
Department of Obstetrics & Gynaecology, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Imperial College London, Mint Wing, St Mary's Hospital, London, UK.
Hum Reprod. 2006 May;21(5):1161-5. doi: 10.1093/humrep/dei466. Epub 2006 Jan 23.
Some cases of recurrent first trimester miscarriage (RM)-the loss of three or more consecutive pregnancies at <12 weeks' gestation-have a thrombotic aetiology.
We determined (i) the prevalence of three thrombophilic mutations [factor V Leiden (FVL), prothrombin G20210A (PTG) and methylenetetrahydrofolate reductase (MTHFR) C677T] amongst 357 Caucasian couples with RM and 68 parous Caucasian couples with no history of miscarriage and (ii) the prospective outcome of untreated pregnancies amongst couples with RM in which either partner carried a thrombophilic mutation.
The allele frequencies of FVL (2%), PTG (2%) and MTHFR C677T (31%) were similar between cases and controls. The prevalence of multiple thrombophilic mutations (greater than one mutation) was also similar between cases and controls. Amongst couples in whom either partner carried greater than one thrombophilic allele, the relative risk of miscarriage in a future untreated pregnancy was 1.9 (95% confidence interval, 1.3-2.8) compared with those couples who carried no thrombophilic mutation.
The prevalence of thrombophilic mutations is similar in couples with RM and parous controls. In couples with RM, multiple genetic thrombophilic mutations in either partner significantly increases the risk of miscarriage in a subsequent pregnancy.
部分复发性孕早期流产(RM)病例——妊娠<12周时连续三次或更多次妊娠丢失——存在血栓形成病因。
我们测定了(i)357对患有RM的白种人夫妇和68对无流产史的已生育白种人夫妇中三种血栓形成倾向突变[凝血因子V莱顿(FVL)、凝血酶原G20210A(PTG)和亚甲基四氢叶酸还原酶(MTHFR)C677T]的发生率,以及(ii)一方携带血栓形成倾向突变的RM夫妇中未经治疗妊娠的预期结局。
病例组和对照组中FVL(2%)、PTG(2%)和MTHFR C677T(31%)的等位基因频率相似。病例组和对照组中多种血栓形成倾向突变(大于一种突变)的发生率也相似。在一方携带大于一种血栓形成倾向等位基因的夫妇中,与未携带血栓形成倾向突变的夫妇相比,未来未经治疗妊娠时流产的相对风险为1.9(95%置信区间,1.3 - 2.8)。
患有RM的夫妇和已生育对照组中血栓形成倾向突变的发生率相似。在患有RM的夫妇中,一方存在多种遗传性血栓形成倾向突变会显著增加后续妊娠流产的风险。